文献速递神经核医学肿瘤 PET/CT

基于肿瘤体积校正的11C-甲硫氨酸摄取优化转移性脑肿瘤复发与放射性坏死的诊断鉴别效能

Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake.
PubMed 文献 · EJNMMI Res · 2017-05-23

本研究纳入48例接受伽玛刀放射外科治疗后需鉴别复发与放射性坏死的转移性脑肿瘤患者,共77个病灶,评估11C-甲硫氨酸PET/CT的肿瘤/正常组织比值(T/N比值)及代谢肿瘤体积(MTV)。按MTV将病灶分为三组并分别确定T/N比值最佳截断值,发现MTV校正后的截断值在小型病灶(MTV≤0.5 cm3)中可维持较好的诊断效能。

要点

  • 复发灶平均T/N比值2.25(±1.12)高于放射性坏死灶1.44(±0.22),P<0.001。
  • 非校正T/N比值1.61的灵敏度70.6%、特异度80.8%、诊断准确率74.0%。
  • MTV≤0.5 cm3组校正截断值1.23的灵敏度70.0%、特异度80.0%、准确率73.3%。

核心结论

  • MTV校正的T/N比值截断值可在小型转移性脑肿瘤中维持11C-MET PET/CT的诊断效能。
  • 作者期望该结果有助于11C-MET PET/CT的可重复和标准化解读。

研究设计与样本

  • 48例转移性脑肿瘤患者接受11C-MET PET/CT,用于伽玛刀放射外科治疗后复发与放射性坏死的鉴别诊断。
  • 每个病灶均估算T/N比值和MTV,按MTV标准分为≤0.5 cm3、>0.5且≤4.0 cm3、>4.0 cm3三组。
  • 在各组及全部病灶中通过ROC曲线确定T/N比值最佳截断值,并比较MTV校正后的诊断效能。

主要发现

  • 77个病灶中51个诊断为复发。
  • 复发灶平均T/N比值2.25(±1.12),放射性坏死灶1.44(±0.22),P<0.001。
  • 非校正T/N比值1.61的灵敏度70.6%、特异度80.8%、诊断准确率74.0%。
  • MTV≤0.5 cm3组最佳截断值1.23,0.5 cm3<MTV≤4.0 cm3组1.54,MTV>4.0 cm3组1.85。
  • MTV≤0.5 cm3组使用校正截断值1.23的灵敏度70.0%、特异度80.0%、诊断准确率73.3%。

关键数值与推荐

  • MTV分组标准:≤0.5 cm3;>0.5且≤4.0 cm3;>4.0 cm3。
  • MTV校正T/N比值截断值:≤0.5 cm3组1.23;0.5–4.0 cm3组1.54;>4.0 cm3组1.85。
  • 非校正T/N比值截断值1.61:灵敏度70.6%、特异度80.8%、诊断准确率74.0%。
  • MTV≤0.5 cm3组校正截断值1.23:灵敏度70.0%、特异度80.0%、诊断准确率73.3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumor to normal tissue ratio (T/N ratio) on 11C-methionine (11C-MET) positron emission tomography/computed tomography (PET/CT) is affected by variable factors. We investigated whether T/N ratio cutoff values corrected according to metabolic tumor volume (MTV) could improve the diagnostic performance of 11C-MET PET/CT for diagnosis of recurrence in patients with metastatic brain tumor. Forty-eight patients with metastatic brain tumors underwent 11C-MET PET/CT for differential diagnosis between recurrence and radiation necrosis after gamma knife radiosurgery (GKR). Both T/N ratio and MTV were estimated in each lesion on 11C-MET PET/CT. The lesions were classified into three groups based on MTV criteria (≤ 0.5 cm3; > 0.5, ≤ 4.0 cm3; and > 4.0 cm3). The optimal cutoff values of the T/N ratio from receiver operating characteristic (ROC) curve were determined in each group (MTV-corrected) as well as total lesions (non-corrected). Finally, diagnostic performance of 11C-MET PET/CT was compared with the MTV-corrected cutoff values. RESULTS: Among 77 lesions, 51 were diagnosed with recurrence. The mean T/N ratio was 2.25 (± 1.12) for recurrent lesions and 1.44 (± 0.22) for radiation necrosis (P < 0.001). T/N ratio of 1.61 (non-corrected) provided the best sensitivity, specificity, and diagnostic accuracy (70.6, 80.8, and 74.0%, respectively). Using the MTV criteria, optimal cutoff values of the T/N ratios in each group were 1.23 (MTV ≤ 0.5 cm3), 1.54 (0.5 cm3 < MTV ≤ 4.0 cm3), and 1.85 (MTV > 4.0 cm3). In small-sized lesions (MTV ≤ 0.5 cm3), MTV-corrected cutoff values (1.23) could maintain favorable diagnostic performance with sensitivity, specificity, and diagnostic accuracy (70.0, 80.0, and 73.3%, respectively), compared to non-corrected cutoff values. CONCLUSIONS: MTV-corrected cutoff values of T/N ratio could maintain the diagnostic performance of 11C-MET PET/CT in small sized, metastatic brain tumors. We expect our results to contribute to reproducible and standardized interpretation of 11C-MET PET/CT.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Jung TY, Kim IY, Lim SH, et al. Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake. EJNMMI Res. 2017. PMID: 28536967. doi:10.1186/s13550-017-0293-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。